Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Fujian Yewpark Biological-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Fujian Yewpark Biological’s Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg.
Currently, there are four major cabazitaxel API suppliers globally, including Fujian Yewpark Biological, Sanofi, Tapi Teva and Fuan Pharmaceutical Group etc. Fujian Yewpark Biological is the global leader in this industry. According to our research, Fujian Yewpark Biological had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cabazitaxel market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cabazitaxel market. Detailed analysis of key players, along with key growth strategies adopted by Cabazitaxel industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Fujian Yewpark Biological
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
By Type:
Purity above 99%
Other Purity
By End-User:
Age Below 65
Age Above 65
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cabazitaxel Market
-
1.3 Market Segment by Type
-
1.3.1 USA Cabazitaxel Market Size and Growth Rate of Purity above 99% from 2016 to 2027
-
1.3.2 USA Cabazitaxel Market Size and Growth Rate of Other Purity from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Cabazitaxel Market Size and Growth Rate of Age Below 65 from 2016 to 2027
-
1.4.2 USA Cabazitaxel Market Size and Growth Rate of Age Above 65 from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cabazitaxel Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cabazitaxel by Major Types
-
3.4.1 Market Size and Growth Rate of Purity above 99%
-
3.4.2 Market Size and Growth Rate of Other Purity
4 Segmentation of Cabazitaxel Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cabazitaxel by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cabazitaxel in Age Below 65
-
4.4.2 Market Size and Growth Rate of Cabazitaxel in Age Above 65
5 Market Analysis by Regions
-
5.1 USA Cabazitaxel Production Analysis by Regions
-
5.2 USA Cabazitaxel Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Cabazitaxel Landscape Analysis
-
6.1 West USA Cabazitaxel Landscape Analysis by Major Types
-
6.2 West USA Cabazitaxel Landscape Analysis by Major End-Users
7 South USA Cabazitaxel Landscape Analysis
-
7.1 South USA Cabazitaxel Landscape Analysis by Major Types
-
7.2 South USA Cabazitaxel Landscape Analysis by Major End-Users
8 Middle West USA Cabazitaxel Landscape Analysis
-
8.1 Middle West USA Cabazitaxel Landscape Analysis by Major Types
-
8.2 Middle West USA Cabazitaxel Landscape Analysis by Major End-Users
9 Northeast USA Cabazitaxel Landscape Analysis
-
9.1 Northeast USA Cabazitaxel Landscape Analysis by Major Types
-
9.2 Northeast USA Cabazitaxel Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Fujian Yewpark Biological
-
10.1.1 Fujian Yewpark Biological Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Sanofi
-
10.2.1 Sanofi Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Tapi Teva
-
10.3.1 Tapi Teva Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Fuan Pharmaceutical Group
-
10.4.1 Fuan Pharmaceutical Group Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Cabazitaxel Market Size and Growth Rate of Purity above 99% from 2016 to 2027
-
Figure USA Cabazitaxel Market Size and Growth Rate of Other Purity from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Cabazitaxel Market Size and Growth Rate of Age Below 65 from 2016 to 2027
-
Figure USA Cabazitaxel Market Size and Growth Rate of Age Above 65 from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Cabazitaxel Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cabazitaxel Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cabazitaxel
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cabazitaxel by Different Types from 2016 to 2027
-
Table Consumption Share of Cabazitaxel by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Purity above 99%
-
Figure Market Size and Growth Rate of Other Purity
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cabazitaxel by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cabazitaxel by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Age Below 65
-
Figure Market Size and Growth Rate of Age Above 65
-
Table USA Cabazitaxel Production by Regions
-
Table USA Cabazitaxel Production Share by Regions
-
Figure USA Cabazitaxel Production Share by Regions in 2016
-
Figure USA Cabazitaxel Production Share by Regions in 2021
-
Figure USA Cabazitaxel Production Share by Regions in 2027
-
Table USA Cabazitaxel Consumption by Regions
-
Table USA Cabazitaxel Consumption Share by Regions
-
Figure USA Cabazitaxel Consumption Share by Regions in 2016
-
Figure USA Cabazitaxel Consumption Share by Regions in 2021
-
Figure USA Cabazitaxel Consumption Share by Regions in 2027
-
Table West USA Cabazitaxel Consumption by Types from 2016 to 2027
-
Table West USA Cabazitaxel Consumption Share by Types from 2016 to 2027
-
Figure West USA Cabazitaxel Consumption Share by Types in 2016
-
Figure West USA Cabazitaxel Consumption Share by Types in 2021
-
Figure West USA Cabazitaxel Consumption Share by Types in 2027
-
Table West USA Cabazitaxel Consumption by End-Users from 2016 to 2027
-
Table West USA Cabazitaxel Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Cabazitaxel Consumption Share by End-Users in 2016
-
Figure West USA Cabazitaxel Consumption Share by End-Users in 2021
-
Figure West USA Cabazitaxel Consumption Share by End-Users in 2027
-
Table South USA Cabazitaxel Consumption by Types from 2016 to 2027
-
Table South USA Cabazitaxel Consumption Share by Types from 2016 to 2027
-
Figure South USA Cabazitaxel Consumption Share by Types in 2016
-
Figure South USA Cabazitaxel Consumption Share by Types in 2021
-
Figure South USA Cabazitaxel Consumption Share by Types in 2027
-
Table South USA Cabazitaxel Consumption by End-Users from 2016 to 2027
-
Table South USA Cabazitaxel Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Cabazitaxel Consumption Share by End-Users in 2016
-
Figure South USA Cabazitaxel Consumption Share by End-Users in 2021
-
Figure South USA Cabazitaxel Consumption Share by End-Users in 2027
-
Table Middle West USA Cabazitaxel Consumption by Types from 2016 to 2027
-
Table Middle West USA Cabazitaxel Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Cabazitaxel Consumption Share by Types in 2016
-
Figure Middle West USA Cabazitaxel Consumption Share by Types in 2021
-
Figure Middle West USA Cabazitaxel Consumption Share by Types in 2027
-
Table Middle West USA Cabazitaxel Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Cabazitaxel Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Cabazitaxel Consumption Share by End-Users in 2016
-
Figure Middle West USA Cabazitaxel Consumption Share by End-Users in 2021
-
Figure Middle West USA Cabazitaxel Consumption Share by End-Users in 2027
-
Table Northeast USA Cabazitaxel Consumption by Types from 2016 to 2027
-
Table Northeast USA Cabazitaxel Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Cabazitaxel Consumption Share by Types in 2016
-
Figure Northeast USA Cabazitaxel Consumption Share by Types in 2021
-
Figure Northeast USA Cabazitaxel Consumption Share by Types in 2027
-
Table Northeast USA Cabazitaxel Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Cabazitaxel Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Cabazitaxel Consumption Share by End-Users in 2016
-
Figure Northeast USA Cabazitaxel Consumption Share by End-Users in 2021
-
Figure Northeast USA Cabazitaxel Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Fujian Yewpark Biological
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujian Yewpark Biological
-
Figure Sales and Growth Rate Analysis of Fujian Yewpark Biological
-
Figure Revenue and Market Share Analysis of Fujian Yewpark Biological
-
Table Product and Service Introduction of Fujian Yewpark Biological
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Tapi Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tapi Teva
-
Figure Sales and Growth Rate Analysis of Tapi Teva
-
Figure Revenue and Market Share Analysis of Tapi Teva
-
Table Product and Service Introduction of Tapi Teva
-
Table Company Profile and Development Status of Fuan Pharmaceutical Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fuan Pharmaceutical Group
-
Figure Sales and Growth Rate Analysis of Fuan Pharmaceutical Group
-
Figure Revenue and Market Share Analysis of Fuan Pharmaceutical Group
-
Table Product and Service Introduction of Fuan Pharmaceutical Group
-
